UK GMP Manufactured · 260-Volunteer Human Study · Launching in 2026
T-Booster
Science-led immune health

T-Booster supports immune health by enhancing thymus function

T-Booster is a science-led nutritional formulation developed by experienced drug-discovery researchers and evaluated through a randomised, double-blind, placebo-controlled human study.

T-Booster bottle
18 selected ingredientsVitamins, minerals and nutraceuticalsselected through scientific review.
260 volunteersRandomised adult study withT-Booster and placebo groups.
UK GMP route66,000 capsules manufacturedfor study and scale-up learning.
Drug-discovery teamLed by Dr Arif Sheikhand Dr David Brown.
Why the thymus matters

Why the thymus mattersthroughout adult life

The thymus is a specialised immune organ where T cells develop and mature. Its activity naturally reduces with age, making thymus biology central to research on immune ageing.

Illustration showing the thymus behind the breastbone
Anatomy

The thymus sits behind the breastbone

It supports the development, selection and maturation of T cells before they enter circulation.

01

Immune-cell development

New T cells are prepared to recognise threats while limiting inappropriate immune reactions.

02

Natural age-related change

Thymic activity gradually declines over time, reducing the output and diversity of newly formed T cells.

03

A measurable research programme

T-Booster evaluation brings together TREC DNA, blood analysis and questionnaire-reported outcomes.

Learn about thymus biology
T-Booster development

Science-led development18-ingredient formulation

T-Booster combines molecular biology, structural biology, drug-discovery experience, literature review and formulation practicality.

16
Months of development

Structured development

Structured scientific workbefore clinical execution.

13
Researchers involved

Multidisciplinary input

Scientific and clinical teamsworked with formulation experts.

AI
Machine-learning support

AI + expert judgement

Digital tools organised evidenceand supported interaction review.

18
Selected compounds

Formulation discipline

Selected for rationale and safetywith practical manufacturing.

Formulation principles

Principles behind theT-Booster formulation

The formulation is positioned responsibly for immune-health support and does not replace medical care, vaccination, a balanced diet or healthy lifestyle.

Natural formulation

Natural ingredient blend

A broad natural combinationbuilt around thymus andimmune-health biology.

Manufacturing

UK GMP production route

A 66,000-capsule batchsupports manufacturingand the route to market.

Lifestyle compatibility

Vegan-friendly positioning

No artificial colours,with vegan-friendly andallergen-aware positioning.

Human clinical study

Structured humanclinical evaluation

Participant involvement is complete. Final laboratory analysis and statistical interpretation are being completed alongside publication, patent and trademark work.

Study statusParticipation complete
Current phaseFinal analysis
Study siteBSMMU, Dhaka
Duration12 months
  • Randomised
  • Double-blind
  • Placebo-controlled
  • 260 adults
A

TREC DNA

A DNA marker of newly produced T cells.

B

Blood analysis

CBC and immune-cell measures add biological context.

C

Participant experience

18 lifestyle questions; energy, sleep, stress, pain, urinary, mood, skin and sexual stood out.

View study design
Primary endpoint

TREC DNA measured by qPCR to assess thymic output.

Secondary endpoints

CBC, safety, tolerability and questionnaire-reported wellbeing outcomes.

Questionnaire outcomes

Questionnaire signalsin wellbeing outcomes

Baseline and end-of-programme questionnaire responses were compared among participants who reported each concern at baseline. The final questionnaire analysis showed the strongest improvements in energy, sleep, urinary health, mood and sexual wellbeing, with additional improvements in pain, skin and stress. These questionnaire outcomes are presented separately from the laboratory endpoints.

Questionnaire-reported improvement chart
T-Booster film

The science and visionbehind T-Booster

The official presentation brings together the thymus rationale, formulation development, clinical evaluation and the scientific leadership behind T-Booster.

Inside the programme

A science-led consumer-health platform

The film explains how biological evidence, ingredient selection, clinical study design and drug-discovery experience were brought together. Final interpretation and permitted product claims remain subject to scientific and regulatory review.

Thymus biologyImmune ageing18 ingredientsFormulation rationaleHuman clinical studyTREC DNABlood analysisDrug-discovery leadership
Leadership

Drug-discovery leadersbehind T-Booster

T-Booster is led by two internationally experienced drug-discovery scientists whose work spans structural biology, pharmaceutical R&D, formulation and clinical translation.

Dr Md Arif Sheikh, PhD

Dr Md Arif Sheikh

Founder & CEO · PhD

Drug discoverer & cancer scientist

Dr Md Arif Sheikh is the scientific architect behind T-Booster. A molecular and structural biologist with more than 19 years of international drug-discovery experience, he has contributed to over 45 protein structures and leads the programme through formulation, clinical study and launch.

Drug discoveryThymus researchStructural biologyClinical formulationImmune ageingMolecular biologyProtein structuresCancer research Scientific leadership
Institutions and organisations associated with Dr Md Arif Sheikh
Read profile
Dr David Brown, PhD, FRSM, FRSC

Dr David Brown

Scientific advisor · PhD, FRSM, FRSC

Drug discoverer & co-inventor of Viagra

Dr David Brown is a pharmaceutical drug discoverer with more than 50 years of experience across major global companies. A co-inventor on the Viagra patent, he brings disciplined R&D and commercial perspective to T-Booster as scientific advisor.

Industry leadershipDrug discoveryPharmaceutical R&DFormulation strategyImmune ageingMedicinal chemistryGlobal R&DScientific advisory Global portfolio
Institutions and organisations associated with Dr David Brown
Read profile
Investors & strategic partners

Completed clinical worktowards commercial launch

We welcome strategic investors, distributors, consumer-health companies and scientific collaborators.

Explore the investment case
Frequently asked questions

Clear answers aboutT-Booster

Information will continue to be updated as final analysis, publication, IP, regulatory review and launch preparation progress.

Is T-Booster available to buy?

T-Booster is moving towards commercial launch. Contact the team for confirmed availability information.

Has the human study finished?

Participant involvement is complete. Laboratory analysis, statistical interpretation and publication are being finalised.

What is T-Booster intended to do?

It is positioned responsibly as a food supplement intended to support thymus function and healthy immune ageing.

Is this a medical treatment?

No. T-Booster is not intended to diagnose, treat, cure or prevent disease.

Early access

Stay informed asT-Booster moves to launch

Receive development news, scientific updates and confirmed launch information.

Join early access